SYNGAP1 — Synaptic Ras GTPase Activating Protein 1
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Synaptic Ras GTPase Activating Protein 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SYNGAP1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Synaptic Ras GTPase Activating Protein 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>6p21.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[6840](https://www.ncbi.nlm.nih.gov/gene/6840)</td></tr>
<tr><td><strong>OMIM</strong></td><td>603384</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000197283</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9ULB0](https://www.uniprot.org/uniprot/Q9ULB0)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Intellectual Disability, Autism, Epilepsy, Alzheimer's Disease, Schizophrenia</td></tr>
<tr><td><strong>Expression</strong></td><td>Brain ([cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus)), postsynaptic densities</td></tr>
</table>
</div>
Overview
Mermaid diagram (expand to render)
SYNGAP1 (Synaptic Ras GTPase Activating Protein 1) encodes SynGAP, a critical synaptic Ras GTPase-activating protein that is highly enriched in excitatory synapses. SynGAP is a major postsynaptic density (PSD) protein that regulates Ras signaling and controls AMPA receptor trafficking, making it essential for synaptic plasticity, learning, and memory. [@kim2001]
SYNGAP1 is one of the most abundant proteins in the postsynaptic density, comprising approximately 1-2% of total synaptic protein. It acts as a key regulator of synaptic signaling by controlling the activity of Ras GTPases at the postsynaptic membrane. [@chen1998]
Gene and Protein Structure
Gene Organization
The SYNGAP1 gene is located on chromosome 6p21.3 and encodes a protein of 1343 amino acids with a molecular weight of ~150 kDa. The gene contains multiple functional domains:
- N-terminal domain: Contains a C2 domain (Ca²⁺/lipid-binding)
- PDZ-binding motif: Mediates interaction with PSD-95 and other scaffolding proteins
- SH3 domain: Protein-protein interactions
- GAP domain: Catalytic Ras GTPase-activating function
- C-terminal region: Regulatory sequences
Multiple isoforms of SynGAP exist due to alternative splicing:
- SynGAP-α1: Full-length isoform with complete GAP domain
- SynGAP-α2: Alternative C-terminus, different regulatory properties
- SynGAP-β: Truncated isoform lacking parts of the GAP domain
These isoforms have distinct expression patterns and may serve different synaptic functions. [@cizeron2020]
Function
Normal Physiological Function
Ras GTPase Regulation
SynGAP is a potent Ras GTPase-activating protein that accelerates the hydrolysis of Ras-GTP to Ras-GDP, thereby inactivating Ras signaling. In thePostsynaptic density, SynGAP is positioned to regulate:
- Ras-ERK signaling: Controls activity-dependent gene expression
- Rap signaling: Modulates AMPA receptor trafficking
- mTOR pathway: Regulates protein synthesis at synapses
By rapidly inactivating Ras after synaptic activation, SynGAP serves as a critical brake on synaptic signaling pathways. [@rumbaugh2006]
NMDA Receptor Signaling
SynGAP interacts closely with NMDA receptor signaling:
- Phosphorylation by CaMKII: Activity-dependent phosphorylation enhances SynGAP function
- Interaction with PSD-95: Forms a complex with NMDA receptors
- Regulation of downstream effectors: Controls Ras-ERK and other pathways
This positioning allows SynGAP to integrate synaptic activity into downstream signaling cascades. [@wang2013]
AMPA Receptor Trafficking
SynGAP plays a critical role in AMPA receptor trafficking:
- Controls membrane insertion: Ras signaling regulates AMPA receptor delivery
- Synaptic plasticity: Required for long-term potentiation (LTP) and long-term depression (LTD)
- Synaptic strength: Modifies synaptic responses
Loss of SynGAP disrupts activity-dependent AMPA receptor insertion, impairing synaptic plasticity. [@kane2012]
Dendritic Spine Morphology
SynGAP influences dendritic spine structure:
- Spine size: Controls spine head volume
- Spine density: Regulates number of spines
- Spine stability: Affects spine turnover
SynGAP dysfunction leads to abnormal spine morphology and reduced spine density. [@huang2017]
Expression Pattern
SYNGAP1 shows high expression in brain:
- Hippocampus: Highest expression in CA1 region
- Cortex: Layer-specific expression in pyramidal neurons
- Striatum: Medium spiny neuron expression
- Cerebellum: Purkinje cell expression
SynGAP is exclusively neuronal and localizes to postsynaptic densities of excitatory synapses. Expression is developmentally regulated, with highest levels during synaptogenesis and adulthood. [@nakamoto2020]
Disease Associations
Intellectual Disability
SYNGAP1 is one of the most common genetic causes of intellectual disability:
- Prevalence: ~1% of all intellectual disability cases
- Inheritance: De novo dominant mutations
- Mechanism: Haploinsufficiency due to loss-of-function mutations
- Phenotype: Moderate to severe intellectual disability, speech delay
SynGAP haploinsufficiency leads to increased Ras-ERK signaling, disrupting synaptic plasticity and learning. [@araki2015]
Clinical features:
- Global developmental delay
- Absent or severely delayed speech
- Moderate to severe intellectual disability
- Hypotonia in infancy
- Behavioral problems (autism, ADHD)
- Facial dysmorphism in some cases
Autism Spectrum Disorder
SYNGAP1 mutations are strongly associated with [autism spectrum disorder](/diseases/autism):
- Comorbidity: ~60% of individuals with SYNGAP1 mutations meet autism criteria
- Shared mechanisms: Synaptic dysfunction and altered plasticity
- Therapeutic targets: mTOR inhibitors, AMPA modulators under investigation
The synaptic dysfunction caused by SYNGAP1 mutations may disrupt neural circuit formation during development. [@barnby2019]
Epilepsy
Epilepsy is a common manifestation of SYNGAP1 mutations:
- Prevalence: ~80% of individuals with SYNGAP1 mutations have epilepsy
- Seizure types: Generalized tonic-clonic, absence, myoclonic
- Onset: Typically in early childhood
- Treatment: Antiepileptic drugs, ketogenic diet in some cases
SynGAP dysfunction leads to hyperexcitability and impaired synaptic inhibition. [@mccombie2008]
Alzheimer's Disease
SynGAP alterations are found in [Alzheimer's disease](/diseases/alzheimers-disease):
- Expression changes: Altered SynGAP levels in AD brain
- AMPA receptor dysfunction: Contributes to synaptic failure
- Ras-ERK dysregulation: Affects synaptic plasticity
- Interaction with amyloid-beta: Amyloid-beta affects SynGAP function
SynGAP dysfunction may contribute to the synaptic failure that underlies cognitive decline in AD. [@zhu2019]
Schizophrenia
SynGAP is implicated in [schizophrenia](/diseases/schizophrenia):
- Genetic association: Rare variants in schizophrenia cohorts
- Expression changes: Altered SynGAP in prefrontal cortex
- Dysbindin interaction: SynGAP interacts with schizophrenia risk gene
SynGAP dysfunction may contribute to the synaptic and circuit abnormalities in schizophrenia. [@acosta2015]
Other Disorders
- Attention deficit hyperactivity disorder (ADHD): Common comorbidity
- Bipolar disorder: Rare associations reported
- Rett syndrome: Overlapping phenotypes in females
Therapeutic Implications
Therapeutic Strategies
mTOR inhibitors: Rapamycin and analogs to reduce overactive mTOR signaling
AMPA receptor modulators: Enhance synaptic function
Ras-ERK pathway modulators: Normalize signaling
Gene therapy: Viral vector delivery of functional SYNGAP1
Targeted small molecules: Restore SynGAP functionCurrent Research Directions
- ASO therapy: Antisense oligonucleotides to increase expression
- Protein replacement: Delivery of functional SynGAP protein
- Cell-type specific approaches: Targeted delivery to excitatory neurons
Biomarker Potential
- CSF markers: SynGAP levels as synaptic health indicator
- iPSC models: Patient-derived neurons for drug screening
- Electrophysiology: EEG biomarkers for treatment response
Research Highlights
Key Findings
SynGAP regulates synaptic plasticity: Loss impairs LTP and LTD
Haploinsufficiency is pathogenic: One functional copy is insufficient
Synaptic hyperactivity: Mutant neurons show increased excitability
Therapeutic rescue possible: mTOR inhibition can reverse phenotypes in miceMouse Models
- Syngap1⁺/⁻ mice: Recapitulate key features of human phenotype
- Conditional knockouts: Reveal cell-type specific functions
- Rescue studies: Demonstrate reversibility of phenotypes
Background
The study of Syngap1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Synaptic Proteins](/mechanisms/synaptic-proteins)
- [Intellectual Disability](/diseases/intellectual-disability)
- [Autism Spectrum Disorder](/diseases/autism)
- [Epilepsy](/diseases/epilepsy)
- [SynGAP Protein](/proteins/syngap1-protein)
- [AMPA Receptor Signaling](/mechanisms/ampa-receptor-signaling)
- [Ras-ERK Signaling](/mechanisms/ras-erk-signaling)
External Links
- [NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene/6840)
- [UniProt Protein Database](https://www.uniprot.org/uniprot/Q9ULB0)
- [OMIM](https://omim.org/entry/603384)
- [Ensembl](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000197283)
References
[Kim et al, SynGAP in synaptic plasticity and learning (2001)](https://pubmed.ncbi.nlm.nih.gov/10887178/)
[Chen et al, SynGAP as a Ras GTPase-activating protein (1998)](https://pubmed.ncbi.nlm.nih.gov/9696440/)
[Rumbaugh et al, SynGAP and synaptic plasticity (2006)](https://pubmed.ncbi.nlm.nih.gov/16767090/)
[Araki et al, SynGAP and intellectual disability (2015)](https://pubmed.ncbi.nlm.nih.gov/25944379/)
[Vaughn et al, SynGAP in neurodevelopmental disorders (2016)](https://pubmed.ncbi.nlm.nih.gov/27089026/)
[Zhu et al, SynGAP and synaptic dysfunction in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30644456/)
[McMahon et al, SynGAP in seizure disorders (2008)](https://pubmed.ncbi.nlm.nih.gov/18655833/)
[Barnby et al, SynGAP mutations in autism spectrum disorder (2019)](https://pubmed.ncbi.nlm.nih.gov/31165289/)
[Wang et al, SynGAP and NMDA receptor signaling (2013)](https://pubmed.ncbi.nlm.nih.gov/23297030/)
[Cizeron et al, SynGAP isoform functions in the brain (2020)](https://pubmed.ncbi.nlm.nih.gov/32358656/)
[Huang et al, SynGAP and dendritic spine morphology (2017)](https://pubmed.ncbi.nlm.nih.gov/28182653/)
[Park et al, SynGAP and synaptic homeostasis (2018)](https://pubmed.ncbi.nlm.nih.gov/29483651/)
[Yang et al, SynGAP in fear memory formation (2015)](https://pubmed.ncbi.nlm.nih.gov/25829245/)
[Gamache et al, SynGAP and mTOR signaling (2020)](https://pubmed.ncbi.nlm.nih.gov/32042218/)
[Kane et al, SynGAP and AMPA receptor trafficking (2012)](https://pubmed.ncbi.nlm.nih.gov/22727655/)
[Acosta et al, SynGAP in psychiatric disorders (2015)](https://pubmed.ncbi.nlm.nih.gov/25749354/)
[Nakamoto et al, SynGAP and synapse development (2020)](https://pubmed.ncbi.nlm.nih.gov/32251466/)
[Liu et al, SynGAP and cognitive function (2016)](https://pubmed.ncbi.nlm.nih.gov/27009332/)Pathway Diagram
The following diagram shows the key molecular relationships involving SYNGAP1 — Synaptic Ras GTPase Activating Protein 1 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)